Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      The Regeneration Game

      When the hair cells in our ears are lost, they’re gone for good. Can scientists regenerate them – and restore hearing? Carina Santos from our Biomedical Research team tells us more.

      By: Dr Carina Santos | 09 March 2018
      The ear is an extraordinary organ. It’s super-sensitive to sound, allowing us to hear the gentlest whisper or the chirp of a bird in noisy traffic. But it has one distinct drawback. While the eye and nose have millions of receptors, the ear relies on 15,000 hair cells to detect and turn sound into electric signals, the only ‘language’ our brain understands. What’s worse, if we lose any of those 15,000 hair cells, they won’t regenerate. The result is sensorineural hearing loss.

      The ear has three specific parts:
      • the external ear that captures the sound around us
      • the middle ear that amplifies the sound
      • the inner ear that transforms sounds into electric signals. This is done by the hair cells (they have tiny projections that look like hair) that are extraordinarily sensitive to sound. Unfortunately, they’re easily damaged by loud noise, certain drugs, and by the ageing process.

      Watch the birdy

      We can’t regenerate our hair cells – but what about our feathered friends? Birds’ hair cells can be damaged again and again, and they’ll regenerate within weeks. That’s why scientists around the world are doing their utmost to understand how this regeneration takes place (and, as we’ve told you before, they’re studying fish as well as birds).

      Armed with this knowledge, they’ll be able to develop therapies to trigger the regeneration of hair cells in humans. Exciting progress has already been made and some regenerative therapies are being tested on people. In birds, once the hair cells are destroyed, the supporting cells (cells surrounding the hair cells which help them to function) start dividing and give rise to new hair cells, which results in the regeneration of the bird’s hearing. Unfortunately, this doesn’t happen in people – so scientists are developing treatments to give a little push to the supporting cells in the human ear to make them behave like the ones in birds.

      Unlocking potential

      How can ear regeneration, observed in birds and fish, be unlocked in us? Some of the biggest pharmaceutical companies, such as GenVec, and Novartis, are now testing whether this breakthrough therapy is safe. The CGF166 consists of a gene therapy that will give supporting cells the ‘small push’ they need to induce them to produce new hair cells. Gene therapy is a way to introduce genes into cells. In this case, researchers are introducing a gene called Atoh1 into the ear. This activates the cellular pathway in supporting cells that will trigger their conversion into hair cells. It’s being tested in people with profound to severe hearing loss.

      At the same time, a new clinical trial is underway in the UK. Dutch biotech company, Audion Therapeutics, in association with pharmaceutical giants, Eli Lilly, is testing a small-molecule drug called a Gamma Secretase Inhibitor (GSI). This drug inhibits, or blocks, a specific cellular pathway, and induces the formation of new hair cells from supporting cells. When the gene and drug therapies mentioned earlier were tested on animals, the results were encouraging: supporting cells were converted into new hair cells – and the animals’ hearing improved.

      Stem cell therapies

      Equally exciting in terms of curing hearing loss, but at a slightly earlier stage of development, are the stem cell therapies. Stem cells are cells that have the capacity to produce any other cell type in our body. With our funding, Dr Marcelo Rivolta, at the University of Sheffield, has succeeded in producing hair cells, as well as Spiral Ganglia Neurons (SGNs), from embryonic stem cells. SGNs connect the hair cells to the brain. Like the hair cells themselves, they can degenerate and lead to hearing loss. Dr Rivolta and his team were able to produce SGNs from stem cells and transplant them to deaf gerbils. The initial results were very promising – the gerbils recovered 46% of their hearing.

      An ever-growing number of researchers are choosing to work in this field – and more pharmaceutical companies are investing time and money in developing these therapies. This March, we’re holding a major research summit, bringing together pharmaceutical companies, scientists and clinicians. They’ll share progress, discuss the challenges they face – and agree on how to speed up the development of treatments. Watch this space!

      Find out more:

      We depend on your donations so we can fund the best hearing and tinnitus research around the world. Donate today and help us continue our vital work into hearing treatments, so that people can live life to the full again.

      Microscope image of hair cells in the inner ear
      Microscope image of hair cells in the inner ear

      Recent Posts

      EE partnership brings unbeatable packages

      For the first time ever, selected mobile phones with EE Pay As You Go plans, tailored for people who are deaf or have hearing loss, are available from Action on Hearing Loss.

      By: Brian Burns
      17 October 2018

      REGAIN update on the progress so far and a further opportunity for people with hearing loss to take part in the trial

      A team of researchers and clinicians at UCL’s Ear Institute and the Royal National Throat Nose and Ear Hospital are delighted to announce that the REGAIN trial is approaching its first anniversary and are continuing to recruit people with hearing loss to participate in a ground breaking clinical trial to test the safety and efficacy of a new drug that aims to treat sensorineural hearing loss. The criteria for eligibility to participate in the trial has recently been broadened to include participants with hearing loss of up to 20 years duration (see below for further information).

      By: REGAIN
      16 October 2018

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018

      Shining a light on the cochlea

      We fund research across the globe into treatments for hearing loss and tinnitus. One of our newest projects, at the Bionics Institute in Australia, is investigating if we can improve how well cochlear implants work using light.

      By: Dr Tracey Pollard
      11 October 2018

      Recent Posts

      EE partnership brings unbeatable packages

      For the first time ever, selected mobile phones with EE Pay As You Go plans, tailored for people who are deaf or have hearing loss, are available from Action on Hearing Loss.

      By: Brian Burns
      17 October 2018

      REGAIN update on the progress so far and a further opportunity for people with hearing loss to take part in the trial

      A team of researchers and clinicians at UCL’s Ear Institute and the Royal National Throat Nose and Ear Hospital are delighted to announce that the REGAIN trial is approaching its first anniversary and are continuing to recruit people with hearing loss to participate in a ground breaking clinical trial to test the safety and efficacy of a new drug that aims to treat sensorineural hearing loss. The criteria for eligibility to participate in the trial has recently been broadened to include participants with hearing loss of up to 20 years duration (see below for further information).

      By: REGAIN
      16 October 2018

      Preventing hearing loss: the search for treatments

      Medicines like aminoglycoside antibiotics or cisplatin are used to combat life-threatening infections and cancer, respectively, but their use may come at the price of someone’s hearing. Several treatments to prevent the loss of hearing caused by these medicines are currently being developed. Our Translational Research Manager, Dr Carina Santos, tells us more.

      By: Dr Carina Santos
      12 October 2018

      Shining a light on the cochlea

      We fund research across the globe into treatments for hearing loss and tinnitus. One of our newest projects, at the Bionics Institute in Australia, is investigating if we can improve how well cochlear implants work using light.

      By: Dr Tracey Pollard
      11 October 2018

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.